You have read the books. You have watched the interviews. You have nodded along to every piece of advice about staying calm when markets drop. You have told yourself, with great confidence, that you are a long term investor who does not panic. Then your portfolio drops 15% in a week and you become someone […]
The Anatomy of a Panic: What Your Brain Does at -15% Read More »
Most investors treat risk like a single number. One score. One verdict. Portfolio goes up seven percent, down seven percent, and the math says both moves were equally “risky.” This is the logic of standard deviation, and it is, to put it politely, incomplete. The Sortino ratio exists because someone finally asked an obvious question:
Sortino Surgery: 3 Moves to Cut Your Downside Without Touching Your Upside Read More »
There is a strange ritual that happens at every dinner party where someone has made a little money in the market. It starts with a casual mention. Maybe between the salad and the main course. Someone says they got into a stock early. Or a fund. Or crypto. The table gets quiet for half a
The Echo Chamber Portfolio: Why You Only Buy What Your Friends Buy Read More »
There is a story Wall Street loves to tell itself. It goes something like this: the best companies own nothing, control everything, and let someone else deal with the messy, expensive, physical reality of actually making things. Asset light is the aspiration. Capital efficiency is the religion. And the return on invested capital of a
The Asset Light Trap: Why “Lean” Companies Can be the Most Fragile Read More »
You own thirty stocks across five sectors. You hold some bonds. Maybe a sprinkle of international exposure. You sleep well at night because you believe your portfolio is diversified. But what if it is not? What if all that apparent variety is just the same bet wearing different costumes? What if your portfolio, for all
There is a famous line attributed to Baron Rothschild, an 18th century financier who made a fortune during the panic that followed the Battle of Waterloo. “Buy when there is blood in the streets,” he supposedly said, “even if the blood is your own.” It is one of the most quoted phrases in investing history.
Blood in the Streets, Ice in the Veins: A Guide to Cold Blooded Investing Read More »
The same metric. The same formula. Enterprise value divided by revenue. Simple enough that a first year analyst can calculate it, dangerous enough that it has destroyed billions in capital when applied without thinking. EV/Revenue is one of the most popular valuation shortcuts in finance. It tells you how much the market is willing to
Tech vs. Energy: Why EV/Revenue Is Brilliant for One and Fatal for the Other Read More »
You do not have a stock picking problem. You have a dopamine problem. That portfolio full of volatile, high beta names that swing five percent on a Tuesday? It is not a strategy. It is a slot machine you have dressed up in financial language. And the worst part is not that you are losing
Why You Are Addicted to High Beta Stocks (And How to Quit) Read More »
Every company loves to announce big spending. New factories, new technology platforms, new distribution centers. The press releases practically write themselves. “We are investing in our future,” the CEO declares, standing in front of a rendering that looks suspiciously like every other corporate rendering you have ever seen. But here is the question that almost
The ROIC Engine: How to Tell if New Spending is Actually Creating Value Read More »
Most investors have heard the same sermon a thousand times. Buy good assets. Hold them forever. Let compound interest do the heavy lifting. Go to sleep. Wake up rich. It is a beautiful story. It is also incomplete. Buy and hold works the way a hammer works. It is the right tool for a specific
Beyond Buy and Hold: A Guide to Sharpe Ratio Optimization Read More »